19276-03-0Relevant articles and documents
1-SUBSTITUTED-2-(N-PHENYL-N-(PHENYL-METHYL)METHANAMINE)-4,5-DIHYDRO-IMIDAZOLES AND RELATED COMPOUNDS AND THEIR USE IN TREATING CALCIUM OVERLOAD IN BRAIN CELLS
-
, (2008/06/13)
The present patent application discloses compounds of the formula STR1 wherein R 1 is C 1-10 saturated or unsaturated alkyl; or STR2 wherein R'" is H or STR3 R 2 is phenyl which is unsubstituted or substituted one or more times with halogen, CF 3, C. sub.1-6-alkoxy, NO 2, CO 2--C 1-6-alkyl, methyl; benzyl which may be substituted one or more times with halogen, CF 3, C 1-6-alkoxy, NO 2, CO 2--C 1-6-alkyl, methyl; pyridyl; or cyclohexyl;R 3 phenyl which is unsubstituted or substituted one or more times with halogen, CF 3, C 1-6-alkoxy, NO 2, CO 2--C 1-6-alkyl, methyl; naphthyl which may be substituted one or more times with halogen, CF 3, C 1-6-alkoxy, NO 2, CO 2--C 1-6-alkyl, methyl; pyridyl; C 1-6 unsaturated alkyl; furanyl;R 4 is H, C 1-6-alkyl, or benzyl; or STR4 together form STR5 R' and R" are each hydrogen or together form an extra benzo ring; and wherein the dotted line represents an optional extra bond between the two carbon atoms designated α and β, or a pharmaceutically-acceptable addition salt thereof.The compounds are useful as pharmaceuticals, for example in the treatment of Ca overload in brain cells. "
Imidazole derivatives as calcium channel blockers
-
, (2008/06/13)
The present patent application discloses compounds of the formula ψψ ψwhereinψ R1 is C1-10-alkyl which may be branched; C1-10-unsaturated alkyl; or CHR'''''' ψψ ψwherein R'''''' is H or ψψ ψRy is phenyl which may be substituted one or more times with halogen, CF3, C1-6-alkoxy, NO2, CO2-C1-6-alkyl, methyl; benzyl which may be substituted one or more times with halogen, CF3, C1-6-alkoxy, NO2, CO2-C1-6-alkyl, methyl; pyridyl; or cyclohexyl;ψ R3 phenyl which may be substituted one or more times with halogen, CF3, C1-6-alkoxy, NO2, CO2-C1-6-alkyl, methyl; naphthyl which may be substituted one or more times with halogen, CF3, C1-6-alkoxy, NO2, CO2-C1-6-alkyl, methyl; pyridyl; C1-6 unsaturated alkyl; furanyl;ψ R4 is H, C1-6-alkyl, or benzyl;ψ or ψψ ψtogether form ψψ ψR5 is H, or C1-6-alkyl;ψ R'' and R'''' are each hydrogen or together form an extra benzo ring;ψ and wherein the dotted line represents an optional extra bond between the two carbon atoms designated à and á, or a pharmaceutically-acceptable addition salt thereof. ψThe compounds are useful as pharmaceuticals, for example in the treatment of Ca overload in brain cells.ψ
Copper(I) and Copper(II) Complexes of a New Tetradentate Chelating Ligand Containing Imidazole and Thioether Groups. The X-ray Structure of Trigonal-Bipyramidal bromocopper(II) Bromide
Birker, Paul J. M. W. L.,Godefroi, Eric F.,Helder, Janneke,Reedijk, Jan
, p. 7556 - 7560 (2007/10/02)
The synthesis and characterization of a new potentially tetradentate chelating imidazole-thioether ligand 1,6-bis(N-benzylimidazol-2-yl)-2,5-dithiahexane, CH2SCH2>2, BBIDH, and some of its CuI, CuII, and ZnII complexes are described.X-ray crystal structure determination showed that the CuII atom in Br*xsolvent is in a trigonal-bipyramidal coordination geometry with two axial imidazole N donor atoms (Cu-N = 1.93(2) and 1.94(2) Angstroem) and two thioether S atoms and a Br- ion in equatorial plane (Cu-S = 2.565(6) and 2.470(6) Angstroem, Cu-Br = 2.417(3) Angstroem).The compounds crystallizes in space group P1/ with a = 8.397(2), b = 11.415(2), and c = 18.016(2) Angstroem, α = 103.74(1), β = 94.49(2), and δ = 100.48(2) deg, and Z = 2.Intensities of 3982 unique reflections (θ 2?(I) to a final R value of 0.071.From ESR and visible spectra, it was inferred that other solid CuII compounds also have a trigonal-bipyramidal coordination geometry, with H2O as the fifth ligand if no halogenide ions are available.The spectra of solutions of the CuII compounds indicate a change in coordination geometry.In I(BBIDH)>+, the Cu atom is probably linearly coordinated by two N atoms.The ZnCl2 adduct is a nonelectrolyte.The coordination chemistry of this imidazole-thioether ligand is in this respect not different from its earlier reported benzimidazole-containing analogon, (C7H5N2CH2SCH2)2, justifying the use of benzimidazole derivatives in model systems for the coordination of Cu in copper proteins.
